Z-0837-2021 Class II Ongoing

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-0837-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 23, 2020 and is designated Class II. Reason for recall: The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium… The recall status is ongoing. Affected quantity: 5079 cases.

Recall details

Product Type
Devices
Report Date
Jan 20, 2021
Initiation Date
Nov 23, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5079 cases

Product description

Naturalyte Liquid Acid concentrate bottles, Product Code 08-3251-9 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Reason for recall

The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.

Distribution pattern

US Nationwide distribution.

Code information

Lot Numbers: 20LXAC058 20LXAC078 20LXAC096 20NXAC011 20NXAC012 Additional Affected lots as of 3/17/21: 20LXAC060 20NXAC026 20LXAC045 20LXAC043 20LXAC078 20NXAC012 20LXAC058 20LXAC096 20NXAC011 20LXAC059 20LXAC044 20LXAC079

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0837-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0837-2021. Report a data issue: hello@regdatalab.com.